HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation-Reference-Cited by-同舟云学术

HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation

Published:2013-11-08 Issue:10 Volume:134 Page:2468-2477
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Qiu Miao-Zhen¹,Li Qian²,Wang Zhi-Qiang¹,Liu Tian-Shu²,Liu Qing³,Wei Xiao-Li¹,Jin Ying¹,Wang De-Shen¹,Ren Chao¹,Bai Long¹,Zhang Dong-Sheng¹,Wang Feng-Hua¹,Li Yu-Hong¹,Xu Rui-Hua¹

Affiliation:

1. Department of Medical Oncology; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Guangzhou China

2. Department of Medical Oncology; Zhongshan Hospital, Fudan University; Shanghai China

3. Department of Epidemiology; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Guangzhou China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

2. Cancer epidemiology and control in North-Western and Central Asia - past, present and future;Moore;Asian Pac J Cancer Prev,2010

3. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer;Murad;Cancer,1993

4. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer;Pyrhonen;Br J Cancer,1995

5. Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom. Capecitabine and oxaliplatin for advanced esophagogastric cancer;Cunningham;N Engl J Med,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023;Cancer Communications;2023-12-31

2. Current prognostic factors of advanced gastric cancer patients treated with chemotherapy: real world data from a Japanese 12 institutions;Japanese Journal of Clinical Oncology;2023-07-29

3. Role of PPP2R1A in Regulation of Cell Proliferation in HeLa Cells;J BIOL REG HOMEOS AG;2023

4. A CT-based radiomics signature for prediction of HER2 overexpression and treatment efficacy of trastuzumab in advanced gastric cancer;Translational Cancer Research;2022-12

5. Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma;Cell Reports Medicine;2022-11